Abstract TP195: Risk Factors And Outcome Of Cerebrovascular Complications In Transplant Recipients

Angel J Cadena,Parneet Grewal,Mathew Gregoski,Shelly Ozark

DOI: https://doi.org/10.1161/str.54.suppl_1.TP195

IF: 10.17

2023-02-04

Stroke

Abstract:Stroke, Volume 54, Issue Suppl_1, Page ATP195-ATP195, February 1, 2023. Introduction:Post Transplant patients experience a great variety of cerebrovascular (CV) complications including ischemic stroke (IS), TIA, SAH, ICH, and posterior reversible encephalopathy syndrome (PRES). These increase mortality & morbidity in an already susceptible population but the incidence of these complications, risk factors, and outcomes in transplant recipients have not been examined in detail.Methods:Design:A retrospective observational study.Population:Patients >18 years of age who underwent solid organ transplantation since 2012 at a tertiary care center. Patients were divided into 2 groups, with CV complications and without.Outcomesof interest were the proportion of CV complications, length of stay (LOS), discharge disposition, functional outcomes (defined by a mRS), and survival time post-transplant.Results:A total of 94 patients met the inclusion criteria (31% (n=29) with CV complications vs 69% (n=65) patients without). The median age was 57.5 years (51.41 vs 45.75 p>0.05). IS was the most prevalent CV complication (n=13, 44%, most common etiology was cryptogenic 76.9% (n=11)) followed but ICH (n=6, 20%), and most of CV complications occurred within 1 year post-transplant (n=17, 58.6%). Patients with past history of TIA or stroke were more likely to have a CV complication post-transplant (OR 0.66 vs 4.89, p=0.05) but there was no significance for the other cardiovascular risk factors when compared to transplant recipients with no complications. Patients with complications were more likely to have lung transplants (p<0.05) and to be discharged to hospice or dead than those without complications, who were more likely to have kidney transplants (p<0.05) and to be discharged home (p 0.05).Conclusions:Post-transplant patients, especially lung transplants, have a high incidence of CV complications including stroke and higher case fatality. There was an association between a history of TIA or IS and subsequent CV events in our patient population. We did not demonstrate any difference in LOS, demographical characteristics, use of antithrombotic, or length of survival post-transplant in both the groups.

peripheral vascular disease,clinical neurology